These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. McArdle's disease and anaesthesia: case reports. Review of potential problems and association with malignant hyperthermia. Bollig G; Mohr S; Raeder J Acta Anaesthesiol Scand; 2005 Sep; 49(8):1077-83. PubMed ID: 16095447 [TBL] [Abstract][Full Text] [Related]
5. Follow-up of patients tested for malignant hyperthermia susceptibility. Scala D; Di Martino A; Cozzolino S; Mancini A; Bracco A; Andria B; Tammaro A; Savoia G Eur J Anaesthesiol; 2006 Sep; 23(9):801-5. PubMed ID: 16780615 [TBL] [Abstract][Full Text] [Related]
6. [Diagnosis of susceptibility to malignant hyperthermia in children]. Krivosic-Horber R; Adnet P; Krivosic I; Reyford H Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268 [TBL] [Abstract][Full Text] [Related]
7. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy. Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824 [TBL] [Abstract][Full Text] [Related]
8. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study. Schuster F; Metterlein T; Negele S; Kranke P; Muellenbach RM; Schwemmer U; Roewer N; Anetseder M Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904 [TBL] [Abstract][Full Text] [Related]
9. [Malignant hyperthermia; two cases of MH in the presence of general anesthesia and performing caffeine contracture test]. Tateishi M; Sumita S; Watanabe H; Kumeta H; Narimatsu E; Namiki A Masui; 1989 Apr; 38(4):546-51. PubMed ID: 2724520 [TBL] [Abstract][Full Text] [Related]
10. [Anesthesiologic management of susceptible children at risk for malignant hyperthermia]. Ferrari F; D'Alessandro S; Pietrandrea G; Villani A Minerva Anestesiol; 1997 Oct; 63(10):311-4. PubMed ID: 9567608 [TBL] [Abstract][Full Text] [Related]
11. [General anesthesia in infants]. Czekuć E; Cwizewicz-Adamska J; Cukier K; Ryterski S; Pawłowska-Wójcik M Probl Med Wieku Rozwoj; 1979; 9():235-45. PubMed ID: 400770 [TBL] [Abstract][Full Text] [Related]
12. Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: an experimental approach from a single laboratory. Weisshorn R; Wappler F; Fiege M; Gerbershagen MU; Kolodzie K; Alberts P; Horn EP; Schulte Am Esch J J Clin Anesth; 2004 Aug; 16(5):353-7. PubMed ID: 15374556 [TBL] [Abstract][Full Text] [Related]
13. [Malignant hyperthermia in Austria. III. Anesthesia in susceptible patients]. Mauritz W; Hackl W; Sporn P; Steinbereithner K Anaesthesist; 1988 Aug; 37(8):522-8. PubMed ID: 3177878 [TBL] [Abstract][Full Text] [Related]
14. Anesthesia in malignant hyperthermia susceptible patients. Mauritz W; Hackl W; Winkler M; Sporn P; Steinbereithner K Acta Anaesthesiol Belg; 1990; 41(2):87-94. PubMed ID: 1973553 [TBL] [Abstract][Full Text] [Related]
18. Muscle biopsy and in vitro contracture test in subjects with idiopathic HyperCKemia. Malandrini A; Orrico A; Gaudiano C; Gambelli S; Galli L; Berti G; Tegazzin V; Dotti MT; Federico A; Sorrentino V Anesthesiology; 2008 Oct; 109(4):625-8. PubMed ID: 18813041 [TBL] [Abstract][Full Text] [Related]
19. The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience. Glauber V; Ben Abraham R; Zweig A; Perel A Isr J Med Sci; 1997 Oct; 33(10):643-7. PubMed ID: 9397136 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the in vitro caffeine-halothane contracture test with the Ca-induced Ca release rate test in patients suspected of having malignant hyperthermia susceptibility. Oku S; Mukaida K; Nosaka S; Sai Y; Maehara Y; Yuge O J Anesth; 2000 Jan; 14(1):6-13. PubMed ID: 14564603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]